During the 8th Microbiome Movement – Drug Development Summit, held in London at the end of January, MicrobiomePost discussed with Clara Desvignes, Head of Microbiome at VCLS, about the continuously evolving regulatory landscape on Fecal Microbiome Transplant.
FMT in USA and EU: how the regulatory landscape is evolving
Clara Desvignes, Head of Microbiome at VCLS, spoke about the continuously evolving regulatory landscape on Fecal Microbiome Transplant.
Latest related content
